Sanofi’s venglustat succeeds in Phase 3 Gaucher trial but fails separate study in Fabry diseasenews2026-02-02T12:12:25+00:00February 2nd, 2026|Endpoints News|
Pharming’s immunodeficiency drug gets CRL for use in younger patientsnews2026-02-02T11:52:52+00:00February 2nd, 2026|Endpoints News|
How RNA reveals clues to life’s origins on Earthnews2026-02-02T11:32:00+00:00February 2nd, 2026|Chemistry World|
